Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/25802
Title: | Pulmonary actinomycosis mimicking metastasis from lung adenocarcinoma |
Authors: | Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı. Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı. Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı. 0000-0002-9732-5340 0000-0003-0298-4157 Ölmez, Ömer Fatih Çubukçu, Erdem Evrensel, Türkkan Kanat, Özkan Kurt, Ender Akyıldız, Elif U. Coşkun, Belkıs Nihan Manavoğlu, Osman AAJ-1027-2021 AAG-7155-2021 26435400000 53986153800 6603942124 55881548500 7006207332 55383413100 55646165400 6602587152 |
Keywords: | Oncology Actinomycosis Adenocarcinoma Pulmonary |
Issue Date: | Oct-2012 |
Publisher: | Karger |
Citation: | Ölmez, Ö. F. vd. (2012). "Pulmonary actinomycosis mimicking metastasis from lung adenocarcinoma". Onkologie, 35(10), 604-606. |
Abstract: | Background: Pulmonary actinomycosis may create a diagnostic and therapeutic dilemma especially in cancer patients. Case Report: A 64-year-old male patient presented with a productive cough, bloody sputum, and weight loss. Thoracic computed tomography (CT) showed a 5-cm mass in the upper lobe of the right lung, and a 2-cm mass in the lower lobe of the left lung. Bronchoscopic examination did not show any endobronchial lesions. CT-guided needle biopsy of the right pulmonary lesion showed lung adenocarcinoma. Whole-body positron emission tomography/CT revealed an increase in fluorodeoxyglucose accumulation in the upper lobe of the right lung, in the lower lobe of the left lung, and in the right hilar and paratracheal lymph nodes. Before chemotherapy was initiated, the patient had to be admitted to the hospital because of massive hemoptysis. Bronchoscopic examination indicated persistent bleeding in the left lower lobe bronchus. The patient underwent diagnostic left thoracotomy, and wedge resection of the lower lobe mass. The diagnosis was pulmonary actinomycosis, and the patient received oral amoxicillin. He underwent successful surgery for the primary disease following 6 cycles of chemotherapy. Conclusion: Oncologists should be aware of rare diseases that may affect management approaches in the treatment of cancer. |
URI: | https://doi.org/10.1159/000342675 https://www.karger.com/Article/Abstract/342675 http://hdl.handle.net/11452/25802 |
ISSN: | 0378-584X |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.